targeting pediatric patients with high-grade gliomas. John Zehner, CEO of SpectronRx, expressed enthusiasm about the ...

Dr Kelly Powers, a podiatrist and Fox News medical contributor, died last week after a battle with aggressive brain cancer ...

Dr Kelly Powers, a podiatrist and Fox News medical contributor, died last week after a battle with aggressive brain cancer ...

Sonodynamic therapy doubled the median overall survival to 15.7 months and tripled progression-free survival to 5.5 months in ...

The physician and surgeon was diagnosed with glioblastoma in 2020 and went through treatment while pregnant with her son ...

Scientists created a new therapeutic design for glioblastoma, the deadliest form of brain cancer. The lab engineered molecules called trispecifics that connect cancer-killing T cells with not just one ...

Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

Glioblastoma is the deadliest form of brain cancer, with less than a 5% five-year survival rate. One of the key contributors ...

Trispecific Design Controls Glioblastoma Tumors in Preclinical ModelsPHILADELPHIA, PA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- ...

Lantern Pharma shares were up 6% to $3.34 after the company said the Food and Drug Administration has granted fast-track designation for the investigational drug candidate LP-184 for the treatment of ...